Skip to content
DataLookout
Menu

NCT07931157

Electromyography-Guidance for Chemodenervation in Facial Synkinesis

StatusCompleted
PhasePhase 4
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Change in Synkinesis Assessment Questionnaire (SAQ) score
Timeframe: Pre-injection and 3 weeks post-injection in each treatment period (crossover at 3 months)
Change in Facial Clinimetric Evaluation (FaCE) score
Timeframe: Pre-injection and 3 weeks post-injection in each treatment period

Secondary (1)

Change in Sunnybrook Facial Grading System (SFGS) composite score

Arms and interventions

Non-Electromyography-guided firstExperimental

participants with an odd final medical record number (MRN) digit received non-electromyography-guided botulinum toxin chemodenervation, then crossed over at 3 months to the electromyography-guided injection. The second treatment used the same injection sites, dosing, and treating physician.

Electromyography-guided firstExperimental

Participants with an even final medical record number (MRN) digit received electromyography-guided botulinum toxin chemo denervation, then crossed over at 3 months to the non-electromyography-guided injection. The second treatment used the same injection sites. dosing, and treating physician.

Drugs: Botulinium Toxin-A

Devices: Electromyography-guided injection

Procedures: Non-Electromyography-guided injection

Sites

1 site in 1 country

  • Vanderbilt Otolaryngology One Hundred OaksNashville, Tennessee, United States